Dr Brendon Monahan
Chief Scientific Officer
Brendon was appointed to the role of Chief Scientific Officer at Cancer Therapeutics CRC in November 2018, after commencing the role of Deputy Chief Scientific Officer in August 2017. Prior to this appointment, he was Director of Discovery Biology within the CRC.
Brendon currently holds an appointment at the Peter MacCallum Cancer Centre where he leads the team of biologists within Cancer Therapeutics CRC’s Translational Biology Laboratory.
Brendon has over 15 years research experience in molecular genetics in various biological systems, with a particular focus on gene regulation and epigenetics. Brendon has had appointments at Massey University, Harvard Medical School, CSIRO and The Walter and Eliza Hall Institute of Medical Research. Brendon has a PhD from the University of Melbourne.